Wrap Technologies (NASDAQ: WRAP) is expanding its public safety technology strategy by connecting remote restraint, scenario-based training, evidence management and emerging threat-detection systems into a more integrated offering. Its portfolio includes the BolaWrap 150 restraint device, WRAP Reality virtual reality training simulator and WrapShield platform, which initially focuses on detecting and responding to unmanned aircraft […]

REV (TSX.V: REVX) (OTCID: REVFF) announced the identification of highly elevated helium concentrations across multiple geological horizons during its maiden drilling program at the Aden Dome Property along the Alberta-Montana border. Geophysical logs also indicated exceptional reservoir properties, supporting the potential for a new helium discovery in the Sweet Grass Corridor. The company has contracted […]

VERAXA Biotech (NASDAQ: VRXA) is expanding its use of human-relevant preclinical testing methods across its antibody-based cancer drug development programs, aiming to improve the clinical relevance of research findings while reducing animal testing. The company is implementing New Approach Methodologies (“NAMs”), including three-dimensional tumor spheroid models and patient-derived tumor models, in support of its BiTAC(R) […]

Quantum BioPharma (NASDAQ: QNTM) has signed a Study Start-Up Agreement with Thermo Fisher Scientific’s clinical research business to support the Phase 2 clinical trial of Lucid-MS, its investigational drug candidate for progressive multiple sclerosis (“MS”). Following U.S. Food and Drug Administration clearance of its Investigational New Drug application in August 2026, the agreement moves the […]

Hydrofarm (NASDAQ: HYFM) announced the closing of its previously disclosed registered direct offering of 1,599,400 common shares at $0.905 per share and concurrent private placement of 7,611,575 unregistered common shares or pre-funded warrants and 9,210,975 common stock purchase warrants. The transactions generated approximately $8.3 million in gross proceeds before fees and expenses. Chairman and CEO […]

SS Innovations (NASDAQ: SSII), a developer of innovative surgical robotic technologies, showcased its surgical robotics platform in a series of remote operations during October medical conferences in Spain and India, including a robotic-assisted cardiac procedure performed by a surgeon approximately 7,500 miles from the patient (https://ibn.fm/EZFDT). The demonstrations featured the company’s SSi Mantra surgical robotic […]

FingerMotion (NASDAQ: FNGR) announced that it has entered into a non-binding term sheet with BlueFlare Group Holdings Inc., a Calgary-based developer of behind-the-meter power generation and modular high-performance computing infrastructure, regarding a potential business combination. The proposed transaction would create a North American infrastructure company focused on providing on-site power and computing capacity to enterprise […]

Silynxcom (NYSE American: SYNX), a developer of advanced soldier-worn tactical communication solutions, is developing an artificial intelligence-powered wearable drone-detection system designed to warn soldiers of approaching unmanned aircraft, marking a strategic move by the tactical communications company into the counter-drone defense market. Announced on October 21, the prototype-stage platform is being designed to identify drone […]

Versus Systems (NASDAQ: VS) is expanding its audience-engagement offerings through Drinkfinger, a QR-enabled beverage carrier that connects live-event attendees with mobile games, rewards and branded content. In a recent IBN Stock2Me Podcast appearance, CEO Luis Goldner and other members of the leadership team discussed plans to target Latin American markets, including Brazil and Mexico, where […]

Regentis Biomaterials (NYSE American: RGNT) was featured in a recent article that discussed the company’s efforts to advance its regenerative cartilage repair technology, GelrinC, as orthopedic medicine increasingly emphasizes durable, long-term treatment outcomes. The company’s lead product is a cell-free, off-the-shelf degradable hydrogel implant designed to support the regeneration of knee cartilage, gradually resorbing over approximately […]

Annovis Bio (NYSE: ANVS), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy buntanetap for Alzheimer’s and Parkinson’s diseases, announced that Founder, President and CEO Maria Maccecchini, Ph.D., will participate in two industry conferences in November. At U.S. Biotech Day 2026, scheduled for Nov. 16-17 in Philadelphia, Maccecchini will join a panel discussion […]

Autonomous drones and other unmanned systems are designed to carry out missions with varying degrees of human oversight. But their capabilities depend on more than their ability to fly or navigate. They also depend on communications links connecting platforms with operators, onboard control systems that execute mission instructions, and reliable data that supports decision-making. These […]